SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 13, 2004.
BioTime, Inc.
(Exact name of registrant as specified in its charter)
California 1-12830 94-3127919
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
935 Pardee Street
Berkeley, California 94710
(Address of principal executive offices)
(510) 845-9535
(Registrant's telephone number, including area code)
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit
Numbers Description
99.1 Press Release dated May 13, 2004.
Item 12. Results of Operations and Financial Condition
On May 13, 2004, BioTime, Inc. issued a press release announcing its
financial results for the first quarter of 2004. A copy of the press release is
attached as Exhibit 99.1, which, in its entirely, is incorporated herein by
reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOTIME, INC.
Date: May 13, 2004 By /s/ Judith Segall
----------------------------------
Vice President - Operations
Member, Office of the President
2
Exhibit
Numbers Description
99.1 Press Release dated May 13, 2004
3